Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen ...

Patients with Parkinson’s disease (PD) suffer from a variety of movement disorders caused by a breakdown of brain neurons.

The Landmark programme will look at what causes Parkinson's, and what triggers the spread through the brain and then causes ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A groundbreaking study will investigate Parkinson’s disease in unprecedented detail, with the aim of discovering a cure for the condition.

Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...